 | • レポートコード：MRC23Q38213 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（2-3日） • 産業分類：医薬品 |
| Single User | ￥435,000 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥870,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界のピロキシカムAPI市場について調査・分析し、世界のピロキシカムAPI市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（純度≧99%、純度≧99.5%）、用途別セグメント分析（錠剤、カプセル、注射剤、軟膏）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、SK Chemicals、Pfizer、Nostrum、Mylan、Teva、Viwit Pharmaceutical、Pidi Pharmaceutical、Maoxiang Pharmaceutical、Jumpcan Pharmaceutical、Changjiang Pharmaceutical、XinAn Pharmaceutical、Jiangxi Pharmaceuticalなどが含まれています。世界のピロキシカムAPI市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、ピロキシカムAPI市場規模を推定する際に考慮しました。本レポートは、ピロキシカムAPIの世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、ピロキシカムAPIに関するビジネス上の意思決定に役立てることを目的としています。 ・ピロキシカムAPI市場の概要 - 製品の定義 - ピロキシカムAPIのタイプ別セグメント - 世界のピロキシカムAPI市場規模：タイプ別分析（純度≧99%、純度≧99.5%） - ピロキシカムAPIの用途別セグメント - 世界のピロキシカムAPI市場規模：用途別分析（錠剤、カプセル、注射剤、軟膏） - 世界のピロキシカムAPI市場規模予測（2018年-2029年） - ピロキシカムAPIの平均価格推移（2018年-2029年） - 前提条件と制限事項 ・メーカー別競争状況 - メーカー別市場シェア - 世界の主要メーカー、業界ランキング分析 - メーカー別平均価格 - ピロキシカムAPI市場の競争状況およびトレンド ・ピロキシカムAPIの地域別市場規模 - 北米のピロキシカムAPI市場規模（2018年-2029年） - アメリカのピロキシカムAPI市場規模（2018年-2029年） - ヨーロッパのピロキシカムAPI市場規模（2018年-2029年） - アジア太平洋のピロキシカムAPI市場規模（2018年-2029年） - 中国のピロキシカムAPI市場規模（2018年-2029年） - 日本のピロキシカムAPI市場規模（2018年-2029年） - 韓国のピロキシカムAPI市場規模（2018年-2029年） - インドのピロキシカムAPI市場規模（2018年-2029年） - オーストラリアのピロキシカムAPI市場規模（2018年-2029年） - 中南米のピロキシカムAPI市場規模（2018年-2029年） - 中東・アフリカのピロキシカムAPI市場規模（2018年-2029年） ・タイプ別セグメント：純度≧99%、純度≧99.5% - 世界のピロキシカムAPIのタイプ別販売量（2018年-2023年） - 世界のピロキシカムAPIのタイプ別売上（2018年-2023年） - 世界のピロキシカムAPIのタイプ別価格 ・用途別セグメント：錠剤、カプセル、注射剤、軟膏 - 世界のピロキシカムAPIの用途別販売量（2018年-2023年） - 世界のピロキシカムAPIの用途別売上（2018年-2023年） - 世界のピロキシカムAPIの用途別価格 ・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向 SK Chemicals、Pfizer、Nostrum、Mylan、Teva、Viwit Pharmaceutical、Pidi Pharmaceutical、Maoxiang Pharmaceutical、Jumpcan Pharmaceutical、Changjiang Pharmaceutical、XinAn Pharmaceutical、Jiangxi Pharmaceutical ・産業チェーンと販売チャネルの分析 - ピロキシカムAPI産業チェーン分析 - ピロキシカムAPIの主要原材料 - ピロキシカムAPIの販売チャネル - ピロキシカムAPIのディストリビューター - ピロキシカムAPIの主要顧客 ・ピロキシカムAPI市場ダイナミクス - ピロキシカムAPIの業界動向 - ピロキシカムAPI市場の成長ドライバ、課題、阻害要因 ・調査成果および結論 ・調査方法とデータソース |
Highlights
The global Piroxicam API market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Piroxicam API is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Piroxicam API is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Piroxicam API include SK Chemicals, Pfizer, Nostrum, Mylan, Teva, Viwit Pharmaceutical, Pidi Pharmaceutical, Maoxiang Pharmaceutical and Jumpcan Pharmaceutical, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Piroxicam API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Piroxicam API.
The Piroxicam API market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Piroxicam API market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Piroxicam API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
SK Chemicals
Pfizer
Nostrum
Mylan
Teva
Viwit Pharmaceutical
Pidi Pharmaceutical
Maoxiang Pharmaceutical
Jumpcan Pharmaceutical
Changjiang Pharmaceutical
XinAn Pharmaceutical
Jiangxi Pharmaceutical
Segment by Type
Purity≥ 99%
Purity≥ 99.5%
Segment by Application
Tablets
Capsule
Injection
Ointment
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Piroxicam API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Piroxicam API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Piroxicam API Market Overview
1.1 Product Overview and Scope of Piroxicam API
1.2 Piroxicam API Segment by Type
1.2.1 Global Piroxicam API Market Value Comparison by Type (2023-2029)
1.2.2 Purity≥ 99%
1.2.3 Purity≥ 99.5%
1.3 Piroxicam API Segment by Application
1.3.1 Global Piroxicam API Market Value by Application: (2023-2029)
1.3.2 Tablets
1.3.3 Capsule
1.3.4 Injection
1.3.5 Ointment
1.4 Global Piroxicam API Market Size Estimates and Forecasts
1.4.1 Global Piroxicam API Revenue 2018-2029
1.4.2 Global Piroxicam API Sales 2018-2029
1.4.3 Global Piroxicam API Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Piroxicam API Market Competition by Manufacturers
2.1 Global Piroxicam API Sales Market Share by Manufacturers (2018-2023)
2.2 Global Piroxicam API Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Piroxicam API Average Price by Manufacturers (2018-2023)
2.4 Global Piroxicam API Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Piroxicam API, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Piroxicam API, Product Type & Application
2.7 Piroxicam API Market Competitive Situation and Trends
2.7.1 Piroxicam API Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Piroxicam API Players Market Share by Revenue
2.7.3 Global Piroxicam API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Piroxicam API Retrospective Market Scenario by Region
3.1 Global Piroxicam API Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Piroxicam API Global Piroxicam API Sales by Region: 2018-2029
3.2.1 Global Piroxicam API Sales by Region: 2018-2023
3.2.2 Global Piroxicam API Sales by Region: 2024-2029
3.3 Global Piroxicam API Global Piroxicam API Revenue by Region: 2018-2029
3.3.1 Global Piroxicam API Revenue by Region: 2018-2023
3.3.2 Global Piroxicam API Revenue by Region: 2024-2029
3.4 North America Piroxicam API Market Facts & Figures by Country
3.4.1 North America Piroxicam API Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Piroxicam API Sales by Country (2018-2029)
3.4.3 North America Piroxicam API Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Piroxicam API Market Facts & Figures by Country
3.5.1 Europe Piroxicam API Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Piroxicam API Sales by Country (2018-2029)
3.5.3 Europe Piroxicam API Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Piroxicam API Market Facts & Figures by Country
3.6.1 Asia Pacific Piroxicam API Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Piroxicam API Sales by Country (2018-2029)
3.6.3 Asia Pacific Piroxicam API Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Piroxicam API Market Facts & Figures by Country
3.7.1 Latin America Piroxicam API Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Piroxicam API Sales by Country (2018-2029)
3.7.3 Latin America Piroxicam API Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Piroxicam API Market Facts & Figures by Country
3.8.1 Middle East and Africa Piroxicam API Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Piroxicam API Sales by Country (2018-2029)
3.8.3 Middle East and Africa Piroxicam API Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Piroxicam API Sales by Type (2018-2029)
4.1.1 Global Piroxicam API Sales by Type (2018-2023)
4.1.2 Global Piroxicam API Sales by Type (2024-2029)
4.1.3 Global Piroxicam API Sales Market Share by Type (2018-2029)
4.2 Global Piroxicam API Revenue by Type (2018-2029)
4.2.1 Global Piroxicam API Revenue by Type (2018-2023)
4.2.2 Global Piroxicam API Revenue by Type (2024-2029)
4.2.3 Global Piroxicam API Revenue Market Share by Type (2018-2029)
4.3 Global Piroxicam API Price by Type (2018-2029)
5 Segment by Application
5.1 Global Piroxicam API Sales by Application (2018-2029)
5.1.1 Global Piroxicam API Sales by Application (2018-2023)
5.1.2 Global Piroxicam API Sales by Application (2024-2029)
5.1.3 Global Piroxicam API Sales Market Share by Application (2018-2029)
5.2 Global Piroxicam API Revenue by Application (2018-2029)
5.2.1 Global Piroxicam API Revenue by Application (2018-2023)
5.2.2 Global Piroxicam API Revenue by Application (2024-2029)
5.2.3 Global Piroxicam API Revenue Market Share by Application (2018-2029)
5.3 Global Piroxicam API Price by Application (2018-2029)
6 Key Companies Profiled
6.1 SK Chemicals
6.1.1 SK Chemicals Corporation Information
6.1.2 SK Chemicals Description and Business Overview
6.1.3 SK Chemicals Piroxicam API Sales, Revenue and Gross Margin (2018-2023)
6.1.4 SK Chemicals Piroxicam API Product Portfolio
6.1.5 SK Chemicals Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Corporation Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Piroxicam API Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Pfizer Piroxicam API Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Nostrum
6.3.1 Nostrum Corporation Information
6.3.2 Nostrum Description and Business Overview
6.3.3 Nostrum Piroxicam API Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Nostrum Piroxicam API Product Portfolio
6.3.5 Nostrum Recent Developments/Updates
6.4 Mylan
6.4.1 Mylan Corporation Information
6.4.2 Mylan Description and Business Overview
6.4.3 Mylan Piroxicam API Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Mylan Piroxicam API Product Portfolio
6.4.5 Mylan Recent Developments/Updates
6.5 Teva
6.5.1 Teva Corporation Information
6.5.2 Teva Description and Business Overview
6.5.3 Teva Piroxicam API Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Teva Piroxicam API Product Portfolio
6.5.5 Teva Recent Developments/Updates
6.6 Viwit Pharmaceutical
6.6.1 Viwit Pharmaceutical Corporation Information
6.6.2 Viwit Pharmaceutical Description and Business Overview
6.6.3 Viwit Pharmaceutical Piroxicam API Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Viwit Pharmaceutical Piroxicam API Product Portfolio
6.6.5 Viwit Pharmaceutical Recent Developments/Updates
6.7 Pidi Pharmaceutical
6.6.1 Pidi Pharmaceutical Corporation Information
6.6.2 Pidi Pharmaceutical Description and Business Overview
6.6.3 Pidi Pharmaceutical Piroxicam API Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Pidi Pharmaceutical Piroxicam API Product Portfolio
6.7.5 Pidi Pharmaceutical Recent Developments/Updates
6.8 Maoxiang Pharmaceutical
6.8.1 Maoxiang Pharmaceutical Corporation Information
6.8.2 Maoxiang Pharmaceutical Description and Business Overview
6.8.3 Maoxiang Pharmaceutical Piroxicam API Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Maoxiang Pharmaceutical Piroxicam API Product Portfolio
6.8.5 Maoxiang Pharmaceutical Recent Developments/Updates
6.9 Jumpcan Pharmaceutical
6.9.1 Jumpcan Pharmaceutical Corporation Information
6.9.2 Jumpcan Pharmaceutical Description and Business Overview
6.9.3 Jumpcan Pharmaceutical Piroxicam API Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Jumpcan Pharmaceutical Piroxicam API Product Portfolio
6.9.5 Jumpcan Pharmaceutical Recent Developments/Updates
6.10 Changjiang Pharmaceutical
6.10.1 Changjiang Pharmaceutical Corporation Information
6.10.2 Changjiang Pharmaceutical Description and Business Overview
6.10.3 Changjiang Pharmaceutical Piroxicam API Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Changjiang Pharmaceutical Piroxicam API Product Portfolio
6.10.5 Changjiang Pharmaceutical Recent Developments/Updates
6.11 XinAn Pharmaceutical
6.11.1 XinAn Pharmaceutical Corporation Information
6.11.2 XinAn Pharmaceutical Piroxicam API Description and Business Overview
6.11.3 XinAn Pharmaceutical Piroxicam API Sales, Revenue and Gross Margin (2018-2023)
6.11.4 XinAn Pharmaceutical Piroxicam API Product Portfolio
6.11.5 XinAn Pharmaceutical Recent Developments/Updates
6.12 Jiangxi Pharmaceutical
6.12.1 Jiangxi Pharmaceutical Corporation Information
6.12.2 Jiangxi Pharmaceutical Piroxicam API Description and Business Overview
6.12.3 Jiangxi Pharmaceutical Piroxicam API Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Jiangxi Pharmaceutical Piroxicam API Product Portfolio
6.12.5 Jiangxi Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Piroxicam API Industry Chain Analysis
7.2 Piroxicam API Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Piroxicam API Production Mode & Process
7.4 Piroxicam API Sales and Marketing
7.4.1 Piroxicam API Sales Channels
7.4.2 Piroxicam API Distributors
7.5 Piroxicam API Customers
8 Piroxicam API Market Dynamics
8.1 Piroxicam API Industry Trends
8.2 Piroxicam API Market Drivers
8.3 Piroxicam API Market Challenges
8.4 Piroxicam API Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer